ConductScience.org, home

Comparison · NCT02086500-ab3f2cbd

Prehospital Tranexamic Acid vs Control: 30 Day Mortality

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Prehospital Tranexamic Acid vs Control: 30 Day Mortality. Trial comparisons, record NCT02086500-ab3f2cbd. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02086500-ab3f2cbd

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.08140.05940.111wilson
Risk in group 20.09960.07520.131wilson
Risk difference, group 1 minus group 2-0.0181-0.05620.0199newcombe hybrid score
Risk ratio, group 1 over group 20.8180.5391.24log
Odds ratio, group 1 over group 20.8020.5071.27log
Number needed to treat, for one fewer participant with the outcome on Prehospital Tranexamic Acid than on Control55.2from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: control.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Prehospital Tranexamic Acid1 gram of Tranexamic Acid will be given during emergency medical transport~Tranexamic Acid: 1 gram of prehospital Tranexamic Acid36442OG000
Group 2ControlIdentical volume of saline during emergency medical transport~Saline control: Saline Control45452OG001

Outcome

Type
PRIMARY
Title
30 Day Mortality
Description
Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.
Time frame
30 Day
Population
Because not all patients had available data regarding 30-day mortality (patients were discharged and there 30-day outcome was unable to be determined) there may be differences between the 30Day mortality relative to the other outcomes. There were 5 and 4 patients from each arm that did not have 30-day outcome and thus are different.

Source ClinicalTrials.gov

Trial

Title
Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)
NCT number
NCT02086500
Phases
PHASE3
Conditions
Traumatic Hemorrhage
Interventions
Tranexamic Acid, Saline control
Lead sponsor
Jason Sperry
Results first posted
2020-09-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02086500-ab3f2cbd